Research

In addition to its expertise in developing antibody products, ProSci actively performs research in a variety of disciplines. Among these are tumor-marker discovery, HIV vaccine development, proteomics analysis and stem-cell manipulation. Given our experience in dealing with protein/peptide sequences, epitope selection, antibody/antigen interactions, and immunological response mechanisms, ProSci is in an unique position to not only further its own research, but to assist biotechnology, pharmaceutical and academic organizations in developing their research programs.

• Tumor Marker
• HIV Vaccine
• Proteomics
• Stem Cell Manipulation